Rapid PR & Expert Commentary
Independent news publications cover the stories shaping your industry. Submit your expert commentary and get cited, with first results in minutes.
Submit Expert Commentary for PR →Add your own news briefRecord your thoughts or type. Review your precise quote before submitting.
Diagnostics and laboratories PR works best when expertise answers a real reader question. This page brings together news opportunities relevant to diagnostic labs and testing companies. Focus your commentary on test interpretation, laboratory quality and access to diagnostics. Choose a story below, or submit a brief based on your own informed observations.
Published 2026-09-17
Yahoo Finance reports on this development. Read the source and add your perspective on what it means for your industry.
Consider: What does this development mean for businesses or customers in diagnostics and laboratories?
Published 2026-09-17
Yahoo Finance reports on this development. Read the source and add your perspective on what it means for your industry.
Consider: What does this development mean for businesses or customers in diagnostics and laboratories?
Published 2026-09-16
The Economic Times on MSN reports on this development. Read the source and add your perspective on what it means for your industry.
Consider: What does this development mean for businesses or customers in diagnostics and laboratories?
Published 2026-09-16
Trade Brains on MSN reports on this development. Read the source and add your perspective on what it means for your industry.
Consider: What does this development mean for businesses or customers in diagnostics and laboratories?
Published 2026-09-15
Co-Diagnostics and ReadyGo announced a collaboration to evaluate whether ReadyGo’s GoCollect field sample-preparation system can provide capillary blood or plasma suitable for processing on Co-Dx’s point-of-need PCR platform. The initial focus is decentralized Ebola virus detection, with potential future applications for bloodborne pathogens such as HIV and hepatitis B and C. The companies said compatibility and validation remain to be established and will be addressed in feasibility work.
This directly concerns diagnostics workflows, point-of-need testing, and blood-based molecular assay capabilities relevant to labs and decentralized testing providers.
Consider: What specific validation steps and performance criteria will you use to determine whether GoCollect-prepared blood is compatible with the Co-Dx PCR platform in decentralized settings?
Evergreen perspective
Share practical expertise grounded in the linked industry sources and your own experience.
Consider: What should customers understand before making an important decision?
Evergreen perspective
Share practical expertise grounded in the linked industry sources and your own experience.
Consider: Which priorities will matter most over the coming years, and why?
Make your expertise useful
Explain what a development means, who it affects and what they should consider next. Your commentary can be recorded or typed, then reviewed before submission.
Who can contribute: Diagnostic labs; testing companies.
For a story affecting diagnostics and laboratories, explain one practical consequence connected to test interpretation. Identify the audience affected, the decision they face and what your professional experience helps them understand. Include a specific example you can substantiate; avoid turning a personal observation into a claim about the entire industry.
Use examples only when they reflect your own informed view. You can also bring your own announcement or news brief.
Explore the PR Guide →
Your free trial starts automatically. No license key is needed yet.